Evidence map›Paper›PMID 40268621›Full record

ArticleActa biomaterialia2025

Macromolecular crowding-based biofabrication utilizing unmodified extracellular matrix bioinks.

Seyma Nayir Jordan, Xianmu Li, Alejandro Rossello-Martinez, Zixie Liang, Xiangyu Gong, Hugh Xiao, Michael Mak

Abstract read
In one paragraph

Article in Acta biomaterialia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyma Nayir JordanYale University, Department of Biomedical Engineering, New Haven, CT, USA.
Xianmu LiYale University, Department of Biomedical Engineering, New Haven, CT, USA.
Alejandro Rossello-MartinezYale University, Department of Biomedical Engineering, New Haven, CT, USA.
Zixie LiangYale University, Department of Biomedical Engineering, New Haven, CT, USA.
Xiangyu GongYale University, Department of Biomedical Engineering, New Haven, CT, USA; Stony Brook University, Department of Pharmacological Sciences, Stony Brook, USA.
Hugh XiaoYale University, Department of Biomedical Engineering, New Haven, CT, USA; Stony Brook University, Department of Pharmacological Sciences, Stony Brook, USA.
Michael MakYale University, Department of Biomedical Engineering, New Haven, CT, USA; Stony Brook University, Department of Pharmacological Sciences, Stony Brook, USA. Electronic address: michael.mak@stonybrook.edu.

Funding

TRANSFER GRANT: Systems Biophysics of Multiscale State Transitions in Cells and TissuesR35GM142875 · NIGMS · YALE UNIVERSITY · PI Michael MAK · 2021 to 2026
$2.7M
NIGMS NIH HHS R35 GM142875
6 · The paper itself

Abstract

The extracellular matrix (ECM) is the body's natural cell-scaffolding material, and its structure and content are often imitated for applications in tissue engineering and regenerative medicine to promote biocompatibility. One approach toward biomimicking natural ECMs is to utilize decellularized extracellular matrices (dECMs), which involve removing cellular components from native tissues to preserve natural components. Solubilizing dECMs to produce bioinks therefore holds high potential for 3D biofabrication and bioprinting of bioactive scaffolds and tissues. However, solubilized ECMs have low printability owing to their slow gelation times, which necessitates additional artificial modifications (e.g. crosslinking) to facilitate biofabrication applications. In this study, we demonstrate a method utilizing macromolecular crowding (MMC) to confer printability, via rapid gelation, to solubilized unmodified dECMs from a variety of tissue types - heart, muscle, liver, small intestine, and large intestine. We show cell spreading and contractility in cell-laden dECM gels fabricated through MMC, highlighting biocompatibility with our method. Finally, we demonstrate successful extrusion bioprinting of complex 3D structures using unmodified dECM solutions as bioinks, revealing the potential of our MMC-based fabrication method for layer-by-layer building of user-designed bioinks made from wide-ranging fully physiological tissues. STATEMENT OF SIGNIFICANCE: Decellularized extracellular matrix (dECM) bioinks are among the most promising materials for simulating native organ-specific extracellular matrices. However, standard methods for gelling solubilized dECMs are slow and result in poor mechanical and structural characteristics, reducing printability. dECM solutions are typically supplemented with additional crosslinkers for the formation of robust hydrogels. The crosslinkers may be toxic to cells, and they often need UV light for activation. Here, we present a method that allows wide-ranging dECMs to be easily patternable and 3D printable in their unmodified forms. We demonstrate cell spreading and contractility in cell-laden unmodified dECM gels created demonstrating cell viability and bioactivity. We also demonstrated successful extrusion bioprinting of complex 3D structures utilizing low concentration unmodified dECM bioinks and normal healthy lung fibroblasts.

Indexed as

BioprintingDecellularized Extracellular MatrixExtracellular MatrixInkMacromolecular SubstancesPrinting, Three-DimensionalTissue ScaffoldsAnimalsHumansTissue EngineeringDecellularized Extracellular MatrixMacromolecular SubstancesBioprintingDecellularized extracellular matrixMacromolecular crowdingPEG

Identifiers

PMID40268621
PMCPMC12422595

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.